Skip to content
healthcare.dev
Get a free key

BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE

NDC 76420-534, BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE, tablet, from Asclemed USA, Inc..

Product NDC
76420-534
Status
Listed
Labeler
Asclemed USA, Inc.
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209069
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76420-534 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
76420-534-307642005343030 TABLET in 1 BOTTLE, PLASTIC (76420-534-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/597cbc69-84b1-4255-bed9-53d0c6dc2134

Use it

Look up 76420-534 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76420-534 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76420-534. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.